132 related articles for article (PubMed ID: 34647945)
21. Curcumin suppresses glioblastoma cell proliferation by p-AKT/mTOR pathway and increases the PTEN expression.
Wang Z; Liu F; Liao W; Yu L; Hu Z; Li M; Xia H
Arch Biochem Biophys; 2020 Aug; 689():108412. PubMed ID: 32445778
[TBL] [Abstract][Full Text] [Related]
22. The Multi-Faceted Effect of Curcumin in Glioblastoma from Rescuing Cell Clearance to Autophagy-Independent Effects.
Ryskalin L; Biagioni F; Busceti CL; Lazzeri G; Frati A; Fornai F
Molecules; 2020 Oct; 25(20):. PubMed ID: 33092261
[TBL] [Abstract][Full Text] [Related]
23. Anti-tumor Effects of Curcuminoids in Glioblastoma Multiforme: An Updated Literature Review.
Afshari AR; Jalili-Nik M; Abbasinezhad-Moud F; Javid H; Karimi M; Mollazadeh H; Jamialahmadi T; Sathyapalan T; Sahebkar A
Curr Med Chem; 2021; 28(39):8116-8138. PubMed ID: 33176632
[TBL] [Abstract][Full Text] [Related]
24. New nanomicelle curcumin formulation for ocular delivery: improved stability, solubility, and ocular anti-inflammatory treatment.
Li M; Xin M; Guo C; Lin G; Wu X
Drug Dev Ind Pharm; 2017 Nov; 43(11):1846-1857. PubMed ID: 28665151
[TBL] [Abstract][Full Text] [Related]
25. Curcumin inhibits proliferation-migration of NSCLC by steering crosstalk between a Wnt signaling pathway and an adherens junction via EGR-1.
Chen QY; Jiao DM; Wang LF; Wang L; Hu HZ; Song J; Yan J; Wu LJ; Shi JG
Mol Biosyst; 2015 Mar; 11(3):859-68. PubMed ID: 25578635
[TBL] [Abstract][Full Text] [Related]
26. Co-delivery of Doxorubicin and Curcumin with Polypeptide Nanocarrier for Synergistic Lymphoma Therapy.
Guo W; Song Y; Song W; Liu Y; Liu Z; Zhang D; Tang Z; Bai O
Sci Rep; 2020 May; 10(1):7832. PubMed ID: 32398729
[TBL] [Abstract][Full Text] [Related]
27. Genomic profiling of a Hepatocyte growth factor-dependent signature for MET-targeted therapy in glioblastoma.
Johnson J; Ascierto ML; Mittal S; Newsome D; Kang L; Briggs M; Tanner K; Marincola FM; Berens ME; Vande Woude GF; Xie Q
J Transl Med; 2015 Sep; 13():306. PubMed ID: 26381735
[TBL] [Abstract][Full Text] [Related]
28. miR-519a enhances chemosensitivity and promotes autophagy in glioblastoma by targeting STAT3/Bcl2 signaling pathway.
Li H; Chen L; Li JJ; Zhou Q; Huang A; Liu WW; Wang K; Gao L; Qi ST; Lu YT
J Hematol Oncol; 2018 May; 11(1):70. PubMed ID: 29843746
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-326 sensitizes human glioblastoma cells to curcumin via the SHH/GLI1 signaling pathway.
Yin S; Du W; Wang F; Han B; Cui Y; Yang D; Chen H; Liu D; Liu X; Zhai X; Jiang C
Cancer Biol Ther; 2018 Apr; 19(4):260-270. PubMed ID: 27819521
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic potentials of curcumin in the treatment of glioblstoma.
Shabaninejad Z; Pourhanifeh MH; Movahedpour A; Mottaghi R; Nickdasti A; Mortezapour E; Shafiee A; Hajighadimi S; Moradizarmehri S; Sadeghian M; Mousavi SM; Mirzaei H
Eur J Med Chem; 2020 Feb; 188():112040. PubMed ID: 31927312
[TBL] [Abstract][Full Text] [Related]
31. Verbascoside inhibits progression of glioblastoma cells by promoting Let-7g-5p and down-regulating HMGA2 via Wnt/beta-catenin signalling blockade.
Jia WQ; Zhu JW; Yang CY; Ma J; Pu TY; Han GQ; Zou MM; Xu RX
J Cell Mol Med; 2020 Mar; 24(5):2901-2916. PubMed ID: 32000296
[TBL] [Abstract][Full Text] [Related]
32. Small GTPase RHOE/RND3, a new critical regulator of NF-κB signalling in glioblastoma multiforme?
Sun Q; Dong H; Li Y; Yuan F; Xu Y; Mao S; Xiong X; Chen Q; Liu B
Cell Prolif; 2019 Sep; 52(5):e12665. PubMed ID: 31332862
[TBL] [Abstract][Full Text] [Related]
33. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
[TBL] [Abstract][Full Text] [Related]
34. MiRNA-7 enhances erlotinib sensitivity of glioblastoma cells by blocking the IRS-1 and IRS-2 expression.
Alamdari-Palangi V; Amini R; Karami H
J Pharm Pharmacol; 2020 Apr; 72(4):531-538. PubMed ID: 32026479
[TBL] [Abstract][Full Text] [Related]
35. Alantolactone, a natural sesquiterpene lactone, has potent antitumor activity against glioblastoma by targeting IKKβ kinase activity and interrupting NF-κB/COX-2-mediated signaling cascades.
Wang X; Yu Z; Wang C; Cheng W; Tian X; Huo X; Wang Y; Sun C; Feng L; Xing J; Lan Y; Sun D; Hou Q; Zhang B; Ma X; Zhang B
J Exp Clin Cancer Res; 2017 Jul; 36(1):93. PubMed ID: 28701209
[TBL] [Abstract][Full Text] [Related]
36. PEITC inhibits human brain glioblastoma GBM 8401 cell migration and invasion through the inhibition of uPA, Rho A, and Ras with inhibition of MMP-2, -7 and -9 gene expression.
Chou YC; Chang MY; Wang MJ; Yu FS; Liu HC; Harnod T; Hung CH; Lee HT; Chung JG
Oncol Rep; 2015 Nov; 34(5):2489-96. PubMed ID: 26352173
[TBL] [Abstract][Full Text] [Related]
37. Antiglioma activity of curcumin-loaded lipid nanoparticles and its enhanced bioavailability in brain tissue for effective glioblastoma therapy.
Kundu P; Mohanty C; Sahoo SK
Acta Biomater; 2012 Jul; 8(7):2670-87. PubMed ID: 22484149
[TBL] [Abstract][Full Text] [Related]
38. ApoE enhances nanodisk-mediated curcumin delivery to glioblastoma multiforme cells.
Ghosh M; Ryan RO
Nanomedicine (Lond); 2014 May; 9(6):763-71. PubMed ID: 23879635
[TBL] [Abstract][Full Text] [Related]
39. The tumor suppressor FOXO3a mediates the response to EGFR inhibition in glioblastoma cells.
Ramis G; Villalonga-Planells R; Serra-Sitjar M; Brell M; Fernández de Mattos S; Villalonga P
Cell Oncol (Dordr); 2019 Aug; 42(4):521-536. PubMed ID: 30980364
[TBL] [Abstract][Full Text] [Related]
40. Curcumin and Solid Lipid Curcumin Particles Induce Autophagy, but Inhibit Mitophagy and the PI3K-Akt/mTOR Pathway in Cultured Glioblastoma Cells.
Maiti P; Scott J; Sengupta D; Al-Gharaibeh A; Dunbar GL
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
